Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:diseases:co-infections [06.08.2011] – [Types] paulalberthome:diseases:co-infections [07.03.2011] paulalbert
Line 1: Line 1:
-~~NOTOC~~ 
  
 ====== Co-infections ====== ====== Co-infections ======
Line 8: Line 7:
 Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections. Because the Marshall Protocol activates the innate immune response, a system that is responsive to a range of microbes, there is a good chance the MP targets these infections. Patients on the MP experience an immunopathological reaction in eliminating any microbes including those labelled as co-infections.
  
-===== Types =====+===== Frequently cited types =====
  
   * //**Bartonella**// – A genus of Gram-negative bacteria. Facultative intracellular parasites, //Bartonella// species can infect healthy people but are considered especially important as opportunistic pathogens.   * //**Bartonella**// – A genus of Gram-negative bacteria. Facultative intracellular parasites, //Bartonella// species can infect healthy people but are considered especially important as opportunistic pathogens.
   * //**Borellia**//   * //**Borellia**//
   * //**Babesia**// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified.   * //**Babesia**// – //Babesia// is a protozoan parasite of the blood that causes a hemolytic disease known as Babesiosis. There are over 100 species of //Babesia// identified.
-  * //**Candida albicans**// – //Candida// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, e.g., AIDS, cancer chemotherapy, organ or bone marrow transplantation. According to the Marshall Pathogenesis, patients suffering from chronic diseases are also immunocompromised. //See article [[home:othertreatments:antifungals|antifungal agents]]//. 
   * **Cytomegalovirus** – A viral genus of the viral group known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV. The species that infects humans it is commonly known as human CMV (HCMV) or human herpesvirus-5 (HHV-5), and is the best studied of all cytomegaloviruses.   * **Cytomegalovirus** – A viral genus of the viral group known as Herpesviridae or herpesviruses. It is typically abbreviated as CMV. The species that infects humans it is commonly known as human CMV (HCMV) or human herpesvirus-5 (HHV-5), and is the best studied of all cytomegaloviruses.
   * //**Ehrlicha**// – A genus of rickettsiales bacteria typically transmitted by ticks.    * //**Ehrlicha**// – A genus of rickettsiales bacteria typically transmitted by ticks. 
   * **Epstein-Barr virus**   * **Epstein-Barr virus**
   * //**Rickettsia**// – A genus of non-motile, Gram-negative, non-sporeforming, highly pleomorphic bacteria that can present as cocci (0.1 μm in diameter), rods (1–4 μm long) or thread-like (10 μm long).    * //**Rickettsia**// – A genus of non-motile, Gram-negative, non-sporeforming, highly pleomorphic bacteria that can present as cocci (0.1 μm in diameter), rods (1–4 μm long) or thread-like (10 μm long). 
 +
 +
 +==== Candida albicans ====
 +
 +<relatedarticle> [[home:othertreatments:antifungals|Antifungal agents]] </article>
 +
 +//Candida albicans// is a fungus (a form of yeast) that plays a role in opportunistic oral and genital infections in humans. //C. albicans// biofilms readily form on the surface of implantable medical devices. Systemic fungal infections (fungemias) have emerged as important causes of morbidity and mortality in patients traditionally labelled as immunocompromised, e.g., AIDS, cancer chemotherapy, organ or bone marrow transplantation.  (According to the Marshall Pathogenesis, patients suffering from chronic inflammatory diseases are likewise immunocompromised.) 
 +
 +As the section devoted to antimicrobial peptides (AmPs) explains, the AmP cathelicidin is a component of the innate immune system, and is responsive to fungi.(({{pubmed>long:19817855}}))
 +
 +Antifungal agents such as fluconazole (Diflucan) are sometimes prescribed to treat fungal infections. While some patients have reported feeling better after taking antifungal agents, antifungals interfere with immune function.
 +
 +At least according to one study, patients are a poor judge of whether they have fungal infections.
 +
 +<blockquote>
 +Patient symptom scores were a poor predictor of yeast infections based on yeast culture results. ... Self-reported symptoms are not reliable for diagnosis.
 +
 +//**Susan Hoffstetter** et al.// (({{pubmed>long:18664056}})) </blockquote> 
 +
 +
 ===== Term can be ambiguous ===== ===== Term can be ambiguous =====
  
home/diseases/co-infections.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.